Muñoz-Sáez, E., Moracho, N., Learte, A. I. R., Collignon, A., Arroyo, A. G., Noël, A., Sounni, N. E.* , & Sánchez-Camacho, C.*. (09 June 2023). Molecular Mechanisms Driven by MT4-MMP in Cancer Progression. International Journal of Molecular Sciences, 24 (12), 9944. doi:10.3390/ijms24129944 * These authors have contributed equally to this work. |
Collignon, A. (20 June 2022). Syndecan-1 interaction with MT4-MMP promotes HER2+ breast cancer progression and sensitivity to HER2 inhibitors [Paper presentation]. EACR congrès, Seville, Spain. |
Collignon, A. (08 April 2022). Exploring the functional significance of syndecan-1 shedding by MT4-MMP in HER2+ breast cancer [Poster presentation]. Séminaire Télévie 2022, ULiege, Belgium. |
Collignon, A. (18 February 2022). Exploring the functional significance of syndecan-1 shedding by MT4-MMP in HER2+ breast cancer [Poster presentation]. GIGA cancer Day, Liege, Belgium. |
Luis, G.* , Godfroid, A.* , Nishiumi, S., Cimino, J., Blacher, S., Maquoi, E., Wery, C., Collignon, A., Longuespée, R., MONTERORUIZ, L., Dassoul, I., Maloujahmoum, N., Pottier, C., Mazzucchelli, G., De Pauw, E., Bellahcene, A., Yoshida, M., Noël, A., & Sounni, N. E. (2021). Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biology, 43, 102006. doi:10.1016/j.redox.2021.102006 * These authors have contributed equally to this work. |
Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x |